Exodus Point Capital Management, LP Cure Vac N.V. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Cure Vac N.V. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 255,164 shares of CVAC stock, worth $839,489. This represents 0.01% of its overall portfolio holdings.
Number of Shares
255,164Holding current value
$839,489% of portfolio
0.01%Shares
9 transactions
Others Institutions Holding CVAC
# of Institutions
95Shares Held
15.3MCall Options Held
31.4KPut Options Held
137K-
Israel Englander Millennium Management LLC | New York, Ny2.76MShares$9.08 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$6.5 Million0.0% of portfolio
-
Camber Capital Management LP Boston, MA1.75MShares$5.76 Million0.13% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.6MShares$5.26 Million5.88% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il981KShares$3.23 Million0.0% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $617M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...